Post-Marketing Surveillance of Micardis® (Telmisartan) in Patients With Hypertension

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The primary objective of this survey is to prospectively investigate safety and efficacy in patients with hypertension treated with telmisartan in proper use in medical practice over a long period

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Boehringer Ingelheim
• Treatments: Telmisartan

Criteria

Inclusion Criteria:

• Patients with hypertension

Exclusion Criteria:

Patients with the following conditions

• Patients with a history of hypersensitivity of this product

• Women in pregnancy (included the possibility of pregnancy)

• Patients with severe biliary obstructive disorders or severe hepatic insufficiency